Investors Press Releases Apr 26 2022 Tiziana Life Sciences to participate in a Fireside Chat At the B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference Read More Apr 05 2022 FDA Grants Permission to Enroll up to 8 Additional Secondary Progressive Multiple Sclerosis (SPMS) Patients in the Expanded Access Program with Intranasal Foralumab Read More Mar 25 2022 Tiziana Announces Initiation of Phase 1b Clinical Trial in Crohn’s Disease Patients to Evaluate Oral Capsules of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody Read More btn News View All Events & Presentations Apr 27 2022 at 2:30 PM EDT Apr 27 2022 at 2:30 PM EDT Tiziana Life Sciences to Present at the B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference Read More Mar 14 2022 at 11:00 AM EDT Mar 14 2022 at 11:00 AM EDT Tiziana Life Sciences KOL Event - Foralumab Clinical Update in Multiple Sclerosis; A Landmark Study with Intranasal Immunotherapy featuring 4 Key Opinion Leaders Read More Jan 27 2022 at 4:00 PM EST Jan 27 2022 at 4:00 PM EST B. Riley Fireside chat Read More btn Events View All Interim Reports Interim Results for the Six Months Ended 30 June 2021 563.4 KB bth Interim Reports View All Annual Reports 20 F - Annual Report for the year ended 31 December 2020 1.8 MB btn ARs View All Annual General Meeting Results of General Meeting September 2021 129.9 KB btn AGM View All Scientific Pipeline Progress Learn more × Stock Quote Change Volume Today's Open Previous Close Today's High Today's Low 52 Week High 52 Week Low Stock Chart
Apr 26 2022 Tiziana Life Sciences to participate in a Fireside Chat At the B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference Read More
Apr 05 2022 FDA Grants Permission to Enroll up to 8 Additional Secondary Progressive Multiple Sclerosis (SPMS) Patients in the Expanded Access Program with Intranasal Foralumab Read More
Mar 25 2022 Tiziana Announces Initiation of Phase 1b Clinical Trial in Crohn’s Disease Patients to Evaluate Oral Capsules of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody Read More
Apr 27 2022 at 2:30 PM EDT Apr 27 2022 at 2:30 PM EDT Tiziana Life Sciences to Present at the B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference Read More
Mar 14 2022 at 11:00 AM EDT Mar 14 2022 at 11:00 AM EDT Tiziana Life Sciences KOL Event - Foralumab Clinical Update in Multiple Sclerosis; A Landmark Study with Intranasal Immunotherapy featuring 4 Key Opinion Leaders Read More